VIDEO | by The Street

Radius CEO: Osteoporosis Drug on Track Despite Skittish Stock

YOU MIGHT ALSO LIKE
  • Loading...

YOU MIGHT ALSO LIKE

VIDEO DESCRIPTION:
The recent volatility surrounding Radius Health shares should lessen as the market starts focusing on its osteoporosis drug ...
Abaloparatide, said the company's CEO Robert Ward. Radius Health sold 6.5 million shares of stock $8 a share in a June IPO, raising $52 million.
Posted: 07/31/2014 | Views: 56 | Duration: 02:50
More Info

Comments


YOU MIGHT ALSO LIKE
Loading...

YOU MIGHT ALSO LIKE